Sophia & Sophia Medical

Medical, Scientific and Market Access Solutions for Successful Launch Reasons to choose S&S MedicalInformation for Patients

Scientific Search & Analysis

Innovation and

Intellectual Property 

Core Value Dossiers

Scientific Services – Research, Analysis and Report writing

  • Literature searches, research and reports with evidence based recommendations
  • Scientific Platform slides and updates
  • AMCP dossier and updates 
  • Core Value Dossier and Global Value Dossier
  • Standard Operating Procedure (SOP) and policy writing
  • Risk mitigation – review of SOPs and department policy
  • Freedom To Operate (FTO) searches – chemical substructure and Markush
  • Value messages and updates
  • HTA medical writing
  • Lean 6-sigma process improvement 
  • Attrition rate analysis – review of drugs in development by target class and mechanism of action
  • Competitor landscape analysis
  • Design of mechanism of action videos and Smartfone Health Apps
  • Strategy design and tactical plans 

Payer Opinion for Reimbursement and Pharmacy 

  • Strategic advice about reimbursement and technology appraisals
  • New drug/device opinion on reimbursement
  • Recommended treatment pathways and algorithms
  • Early access programmes and patient access schemes

Therapy Area Expertise

  • Any work related to Systemic Lupus Erythematosus (SLE) including lupus reports, competitor landscape analyses and Scientific Platform – (strategy, CVD, AMCP)
  • CNS – mental health, analgesia
  • Monoclonal antibodies and Biosimilars
  • Rare diseases
  • Gastroenterology
  • All Autoimmune diseases

“A gateway to successful launch.”

Dr Sophia acted as Head of Market Access and Health Outcomes at Sucampo in 2015 and successfully completed two HTA submissions, in addition to supporting us with our value messages and medical writing…….we can thoroughly recommend her work.

Dr Peter Lichtlen, Chief Medical Officer, Sucampo Pharma Europe